Interstitial Lung Disease Clinical Trials

Find Interstitial Lung Disease Clinical Trials Near You

Impact of Capillaroscopy in the Investigation of Diffuse Interstitial Pneumonias

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The investigators hypothesize that in patients with a new diagnosis of Pulmonary Interstitial Disease (PID), adding capillaroscopy to standard care increases the proportion of patients receiving a diagnosis of PID-Connective Tissue Disease (PID-CTD) within the first three months of follow-up, thereby reducing the time to diagnosis and facilitating the implementation of appropriate treatment as quickly as possible. Therefore, To confirm this hypothesis, it is necessary to know the characteristics of capillaroscopy in patients with a new diagnosis of PID.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Male or female over 18 years of age;

• Have received a new diagnosis of PID within the last six months, confirmed by a pulmonologist;

• Have undergone some specific tests within the last six months (Chest CT scan, respiratory function tests (plethysmography and CO transfer capacity measurement, immunological assessment including: screening for FAN, FR, and anti-CCP);

• French-speaking patient with no comprehension difficulties;

• Person affiliated with or beneficiary of a social security system;

• Free, informed, and written consent signed by the participant and the investigator (no later than the day of inclusion and before any examination required by the research).

Locations
Other Locations
France
CHU de Bordeaux - service de rhumatologie
RECRUITING
Bordeaux
Contact Information
Primary
Marie-Elise TRUCHETET, MD, PhD
marie-elise.truchetet@chu-bordeaux.fr
05.56.79.55.56
Backup
Thomas BARNETCHE, PhD
thomas.barnetche@chu-bordeaux.fr
Time Frame
Start Date: 2026-03-16
Estimated Completion Date: 2027-03
Participants
Target number of participants: 48
Treatments
Experimental: Diffuse interstitial lung diseases (DILD)
Sponsors
Leads: University Hospital, Bordeaux

This content was sourced from clinicaltrials.gov